CoverageForm 410-K10-Q8-K13D13G13F

POCI · Precision Optics Corporation, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · POCI

Income Statement

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Revenue$8.71M$7.37M$6.68M$4.53M$4.19M$4.20M$4.82M$5.24M$4.32M$5.89M
Cost of Revenue$3.77M$7.16M$3.08M$3.46M$3.77M$3.08M$3.37M$3.38M$2.86M$3.16M
Gross Profit$2.06M$204.7K$946.4K$1.07M$418.0K$1.12M$1.45M$1.86M$1.46M$2.73M
R&D$267.3K$249.6K$311.8K$317.7K$211.2K$400.7K$221.7K$192.8K$212.8K$208.7K
SG&A$1.85M$1.70M$2.23M$1.66M$2.25M$1.96M$1.93M$1.92M$1.66M$1.82M
Total Operating Expenses$2.12M$1.95M$2.54M$1.98M$2.46M$2.36M$2.16M$2.12M$1.87M$2.03M
D&A--$65.2K--$48.3K--$51.6K-
Operating Income($64.5K)($1.74M)($1.60M)($910.0K)($2.04M)($1.25M)($704.2K)($258.5K)($405.3K)$696.8K
Interest Expense$35.1K$59.7K$64.3K$54.6K$58.5K$59.1K$54.6K$58.5K$59.1K$46.7K
Income Tax$0---------
Net Income($108.3K)($1.78M)($1.64M)($969.7K)($2.10M)($1.31M)($758.8K)($317.1K)($464.4K)$634.4K
EPS - Basic($0.01)($0.23)($0.21)($0.15)($0.30)($0.21)($0.13)($0.05)($0.08)$0.11
EPS - Diluted($0.01)($0.23)($0.21)($0.15)($0.30)($0.21)($0.13)($0.05)($0.08)($0.09)

Balance Sheet

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Cash & Equivalents$10.68M$881.5K$1.39M$1.77M$2.55M$635.6K$405.3K$925.1K$1.37M$2.93M
Accounts Receivable$6.58M$4.87M$4.19M$4.34M$3.43M$3.12M$3.55M$4.22M$4.53M$3.91M
Inventory$3.70M$4.26M$3.88M$3.56M$3.67M$3.46M$2.87M$3.03M$2.97M$2.78M
Accounts Payable$6.24M$6.04M$4.01M$2.91M$1.87M$2.14M$1.40M$1.70M$1.73M$2.43M
Current Assets$21.41M$10.42M$9.86M$10.06M$9.97M$7.51M$7.12M$8.39M$9.24M$9.86M
Total Assets$33.69M$22.90M$22.38M$19.79M$19.62M$17.24M$16.91M$18.27M$19.07M$19.74M
Current Liabilities$10.19M$9.95M$7.62M$6.15M$5.01M$5.34M$4.91M$5.13M$5.13M$5.26M
Long-term Debt$855.8K$1.00M$1.14M$1.29M$1.44M$1.75M$1.90M$1.79M$2.05M$2.18M
Total Liabilities$13.58M$13.57M$11.46M$7.53M$6.44M$7.10M$6.84M--$7.69M
Stockholders' Equity$20.11M$9.33M$10.92M$12.26M$13.18M$10.14M$10.07M$11.26M$11.69M$12.05M
Retained Earnings($60.50M)($60.39M)($58.61M)($56.97M)($55.57M)($52.50M)($51.19M)($49.78M)($48.70M)($48.24M)

Cash Flow

Line itemQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Operating Cash Flow--$78.2K--($318.6K)--($1.37M)-
Investing Cash Flow--($301.8K)--($28.1K)--($43.5K)-
Financing Cash Flow--($158.1K)--$577.0K--($138.9K)-
CapEx-----$24.3K--$30.8K-
Free Cash Flow-----($343.0K)--($1.40M)-

Ratios

MetricQ3 '26Q2 '26Q1 '26Q2 '25Q3 '25Q1 '25Q2 '24Q3 '24Q1 '24Q2 '23
Profitability
Gross margin23.6%2.8%14.2%23.6%10.0%26.6%30.1%35.5%33.9%46.3%
Operating margin-0.7%-23.6%-23.9%-20.1%-48.7%-29.7%-14.6%-4.9%-9.4%11.8%
EBITDA margin---22.9%---28.6%---8.2%-
Net margin-1.2%-24.2%-24.5%-21.4%-50.1%-31.2%-15.7%-6.0%-10.7%10.8%
Free cash flow margin------8.2%---32.5%-
FCF / Net income-----0.26--3.02-
R&D / Revenue3.1%3.4%4.7%7.0%5.0%9.5%4.6%3.7%4.9%3.5%
SG&A / Revenue21.3%23.0%33.4%36.7%53.6%46.8%40.1%36.7%38.3%30.9%
Effective tax rate----------
Return on assets-0.3%-7.8%-7.3%-4.9%-10.7%-7.6%-4.5%-1.7%-2.4%3.2%
Return on equity-0.5%-19.1%-15.0%-7.9%-15.9%-12.9%-7.5%-2.8%-4.0%5.3%
Return on invested capital-0.2%---------
Liquidity
Current ratio2.101.051.291.641.991.411.451.641.801.87
Quick ratio1.740.620.791.061.260.760.871.051.221.35
Cash ratio1.050.090.180.290.510.120.080.180.270.56
Leverage
Debt / Equity0.040.110.100.110.110.170.190.160.180.18
Debt / Assets0.030.040.050.070.070.100.110.100.110.11
Debt / EBITDA----------
Interest coverage-1.8x-29.2x-24.8x-16.7x-34.9x-21.1x-12.9x-4.4x-6.9x14.9x
Equity multiplier1.682.452.051.611.491.701.681.621.631.64
Liabilities / Assets0.400.590.510.380.330.410.40--0.39
Efficiency
Asset turnover0.260.320.300.230.210.240.290.290.230.30
Inventory turnover1.021.680.790.971.030.891.181.120.961.14
Days sales outstanding276d241d229d350d299d272d268d294d383d242d
Days inventory outstanding359d217d460d376d356d410d310d327d380d320d
Days payable outstanding604d308d475d307d181d254d151d183d221d281d
Cash conversion cycle30d151d214d419d473d428d427d438d541d282d
Valuation
P / E----------
P / B1.7x3.5x3.1x2.5x2.2x3.4x----
P / S3.9x4.4x5.0x6.9x6.9x8.3x----
EV / EBITDA----------
Growth
Revenue growth (YoY)108.0%62.8%59.2%-6.2%-20.2%-2.9%-18.1%3.9%-15.0%51.1%
Revenue CAGR (3y)19.9%7.8%9.5%5.1%-3.5%21.6%20.1%28.7%19.8%28.2%
Revenue CAGR (5y)28.8%21.5%21.6%10.1%12.0%10.8%26.7%30.5%22.6%48.6%
Gross profit growth (YoY)392.0%-80.9%-15.3%-26.3%-77.5%-23.7%-46.8%7.1%-15.1%143.4%
Operating income growth (YoY)96.8%-91.5%-27.9%-29.2%-688.4%-207.7%-47.6%-2343.1%-
Net income growth (YoY)94.8%-83.6%-24.8%-27.8%-561.3%-182.3%-20.4%-531.8%-
EPS growth (YoY)96.7%-53.3%0.0%-15.4%-500.0%-162.5%-44.4%28.6%--
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)-----75.6%----
FCF CAGR (5y)----------
Book value growth (YoY)52.6%-23.9%7.8%21.8%17.0%-13.3%-16.4%16.1%30.3%34.3%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-06-30.

Product / service

$19.09M total
Systems Manufacturing$8.29M · 43.4%
Engineering Design Services$4.94M · 25.9%
Ross Optical Industries$3.73M · 19.5%
Micro Optics Lab$2.14M · 11.2%

Peer comparison

Same SIC group: Electromedical & Electrotherapeutic Apparatus

CompanyRevenue (last FY)Net marginROE
BLFS---1.2%
OM$119.48M-68.3%-64.3%
ITGR$1.85B5.5%5.9%
TMDX$605.49M31.4%40.2%
MDT---

Comparing PRECISION OPTICS CORPORATION against the 5 most active filers in the same SIC group.